Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

BridgeBio Pharma, Inc. (BBIO) Insider Trading

3 open-market trades reported since Aug 20, 2026: 0 purchases worth $0 and 3 sales worth $4.42M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Neil KumarCEO0$03$4.42MSep 21, 2026

All trades

BBIO insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 21Sep 17Neil KumarCEOCEO (ind.)▼ SELL10b5-110,00069.08$691K−2.0%Form 4 ↗
Aug 20Aug 18Neil KumarCEOCEO▼ SELL10b5-134,98082.53$2.89M−13%Form 4 ↗
Aug 20Aug 19Neil KumarCEOCEO (ind.)▼ SELL10b5-110,00084.03$840K−1.9%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings